Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • KR vs GSK✓SelectedUSD · GSKKR vs GSK performance historyLatest closeAs of+0.30%11/17
Stock and ETF performance explorer

KR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+94.5%
GSK return
+43.9%
Excess return
+50.5%
Maximum drawdown
-31.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.3%-2.3%+2.6%+0.7%
7D+3.9%-3.0%+6.9%+4.4%
30D+12.0%+0.4%+11.7%+11.9%
3M+27.1%-1.2%+28.3%+27.2%
6M+8.7%+0.9%+7.8%+8.6%
YTD+16.0%+4.0%+12.0%+15.0%
1Y+9.7%+7.3%+2.4%+8.2%
3Y+78.4%+57.1%+21.3%+65.8%
5Y+94.5%+43.0%+51.5%+88.4%
All+94.5%+43.9%+50.5%+88.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling